Publication | Open Access

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy

Favourable OutcomeTumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor ImmunityImmunoeditingImmunotherapeuticsLung CancerImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentTumour-infiltrating Lymphocyte Density